Recent Clinical Disclosures and SMR Award. Highlights from The Society for Medicines Research Symposium

摘要

The symposium featured an international lineup of speakers presenting on the discovery and development of novel therapeutic agents covering a variety of mechanistic approaches in therapeutic areas including oncology, anti-infectives and inflammation. The program also featured the 2019 Society for Medicines Research Award Lecture, given by Dr. Andrew Chan of Genentech, on the discovery and development of ocrelizumab, a humanized anti-CD20 monoclonal antibody for the treatment of multiple sclerosis. The meeting was held at Friends House, London, UK.